FDA
-
-
-
-
-
-
-
Cleveland Clinic to Present Final Results of Phase 1 Clinical Trial for Anixa Biosciences' Breast Cancer Vaccine at 2025 San Antonio Breast Cancer Symposium
-
-
-
-
-
-
-
Anixa Biosciences CEO Provides Letter to Shareholders Outlining Significant Progress and Advancement Towards Potentially Transformative Milestones
-
-
-
-
-
-
-
Anixa Biosciences (ANIX) Announces FDA Approval of Individual Patient IND for its Ovarian Cancer CAR-T Therapy
-
-
-
-
-
-
-
Anixa Biosciences' Ovarian Cancer CAR-T Therapy to be Discussed at Upcoming Emerging Immunotherapeutics for Ovarian Cancer Symposium
-
-
-
-
-
-
-
Anixa Biosciences and Moffitt Cancer Center Report US FDA Request of Additional Information for CAR-T Therapy
-
-
-
-
-
-
-
Anixa Biosciences Announces European Patent Issued for its CAR-T Cancer Therapy
-
-
-
-
-
-
-
Anixa Biosciences Names Novartis Executive Dr. Emanuele Ostuni to Scientific Advisory Board
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

